Regulus: Q4 Earnings Snapshot
By AP News
Published - Mar 21, 2024, 04:24 PM ET
Last Updated - Mar 21, 2024, 04:24 PM EDT
SAN DIEGO (AP) — SAN DIEGO (AP) — Regulus Therapeutics Inc. (RGLS) on Thursday reported a loss of $8.1 million in its fourth quarter.
The San Diego-based company said it had a loss of 40 cents per share.
For the year, the company reported a loss of $30 million, or $1.58 per share.
_____
